Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Understanding Meningococcal Disease
Asian Pac J Trop Med; 2017 Nov; Batista, et al
Neisseria meningitidis, the microbe that causes meningococcal disease, is a uniquely human pathogen since humans are its only natural host. A recent review of the disease sheds light on its clinical course and epidemiology.
- Meningococcal disease takes its greatest toll in semi-arid regions of sub-Saharan Africa.
- The infection is endemic in Brazil, causing occasional outbreaks, epidemics, and sporadic cases throughout the year, with winter episodes being most common.
- Serogroups A and C were responsible for Brazilian epidemics in the 1970s.
- Serogroups B, C, and Y are responsible for most cases in Europe, North and South America, and Australia.
- Among the preventive measures that have helped thwart the spread of the infection are vaccination, chemoprophylaxis, and droplet precautions.
Batista RS, Gomes AP, Dutra Gazineo JL, et al. Meningococcal disease, a clinical and epidemiological review. Asian Pac J Trop Med. 2017;10:1019-1029. doi:10.1016/j.apjtm.2017.10.004.
This Week's Must Reads
Must Reads in Meningitis
Cerebral Venous Thrombosis & Steroids in Meningitis, Open Forum Infect Dis; 2017 Oct; Gallegos, et al
Early Onset GBS Meningitis Drops, Late Onset Jumps, Clin Infect Dis; 2017 Oct 16; Romain, et al
Better Diagnostic Tests for Histoplasma Meningitis, Clin Infect Dis; 2017 Aug 20; Block, et al
Understanding Meningococcal Disease, Asian Pac J Trop Med; 2017 Nov; Batista, et al
Cryptococcal Meningitis Takes Toll on HIV Patients, Clin Infect Dis; 2017 Oct 4; Pasquier, et al